Resources

FRONTEO Commences Drug Repositioning Research on Novel Coronavirus (COVID-19) Using Best-In-Class AI - FRONTEO USA

Written by FRONTEO USA - | Apr 16, 2020 3:00:00 PM
FRONTEO and Kyowa Pharmaceutical Form Partnership to Diagnose Dementia Using Artificial Intelligence
April 15, 2020
FRONTEO has Constructed a Pathway Map of the Coronavirus Infection (COVID-19) to be Published for Use in Therapeutic Drug Selection and Review
April 30, 2020